谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Enfortumab Vedotin (EV) with or Without Pembrolizumab (P) in Patients (pts) Who Are Cisplatin-Ineligible with Previously Untreated Locally Advanced or Metastatic Urothelial Cancer (la/muc): Additional 3-Month Follow-Up on Cohort K Data.

Terence W. Friedlander,Matthew I. Milowsky,Peter H. O'Donnell,Daniel P. Petrylak,Christopher J. Hoimes,Thomas W. Flaig,Nataliya Mar,Helen H. Moon,Rana R. McKay,Mehmet Asim Bilen,Delphine Borchiellini,Marco Iafolla,Anne-Sophie Carret,Yao Yu,Maria Guseva,Ritesh S. Kataria,Jonathan E. Rosenberg

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用 1|浏览33
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要